Core Content Review

Abnormal uterine bleeding in reproductive-aged women - 2Qs (November 2018)

Acute kidney injury - 4Qs (July 2019)

Acute kidney injury - Contrast-induced - 2Qs (July 2020)

Adnexal mass in premenopausal women - 2Qs (November 2019)

Amenorrhea - Primary - 2Qs (November 2018)

Bacterial vaginosis (May 2021)

Benign prostatic hyperplasia - 2Qs (November 2022)

Benign prostatic hyperplasia - 3Qs (January 2019)

Blunt renal trauma (March 2025)

Blunt renal trauma (January 2021)

Breast cancer - Genitourinary symptoms - 3Qs (January 2019)

Cardiovascular kidney metabolic syndrome - 3Qs (May 2025)

Cervical cancer screening >65 years (January 2019)

Cervical cancer screening <65 years - 2Qs (January 2019)

Cervical polyps (March 2022)

Chronic kidney disease- 2Qs (March 2024)

Chronic kidney disease - 2Qs (May 2022)

Chronic kidney disease - 3Qs (July 2018)

Condyloma acuminata - 2Qs (November 2018)

HIV nephropathy (May 2025)

Cranberry for UTI prevention (September 2023)

Diabetes and chronic kidney disease - 3Qs (July 2021)

Diabetic kidney disease - 2Qs (March 2022)

Dyspareunia - 4Qs (January 2024)

Dysmenorrhea - 2Qs (January 2023)

Endometrial polyps - 2Qs (March 2023)

Endometriosis - 2Qs (November 2019)

Epididymitis - 3Qs (May 2021)

Epididymitis and orchitis - 4Qs (November 2024)

Erectile dysfunction - 4Qs (January 2019)

Erectile dysfunction and cardiovascular disease (July 2021)

Genitourinary syndrome of menopause - 3Qs (May 2025)

Hematospermia - 2Qs (May 2020)

Hepatitis C and renal disease - 2Qs (September 2022)

Hypospadius (November 2021)

Hypospadias (July 2020)

IgA nephropathy - 2Qs (September 2020)

Incidental renal cyst - 2Qs (May 2020)

Incontinence - 3Qs (September 2024)

Interstitial cystitis - 2Qs (January 2025)

Intrauterine device - insertion - 2Qs (July 2018)

Intrauterine devices - problems/complications (July 2018)

Intrauterine device - removal (July 2018)

Living kidney donor (March 2019)

Male hypogonadism - 2Qs (November 2018)

Menorrhagia - 3Qs (May 2021)

Measurement of serum proteins (July 2022)

Menopause and depression (July 2023)

Microscopic hematuria - 3Qs (January 2021)

Microscopic hematuria (July 2018)

Minimal change disease (November 2019)

Neonatal hydronephrosis (July 2023)

Nephrolithiasis - 2Qs (July 2022)

Nephrolithiasis - 3Qs (July 2020)

Nephrolithiasis in children - 2Qs (July 2021)

Nephrolithiasis - medical management - 3Qs (July 2021)

Nephrotic syndrome - 2Qs (January 2019)

Paroxysmal nocturnal hemoglobinuria (May 2019)

Pediatric nocturnal enuresis - 4Qs (November 2024)

Pelvic organ prolapse - 2Qs (September 2024)

Peri and postmenopausal bleeding - 3Qs (November 2018)

Polycystic ovarian syndrome - 2Qs (July 2023)

Post-streptococcal glomerulonephritis - 2Qs (November 2021)

Prevention of recurrent renal stones - 2Qs (March 2025)

Prevention of recurrent kidney stones - 3Qs (September 2018)

Prostate cancer – chemoprevention (May 2019)

Prostate cancer screening - 3Qs (January 2025)

Renal artery stenosis - 2Qs (January 2023)

Screening for cervical cancer - 3Qs (July 2023)

Secondary dysmenorrhea (January 2023)

Solitary functioning kidney in children - 2Qs (January 2019)

Syndrome of inappropriate antidiuretic hormone (SIADH) - 3Qs (November 2021)

Syphilis - Congenital - 3Qs (September 2018)

Trichomoniasis (March 2020)

Urethritis (July 2022)

Urinary incontinence - 3Qs (November 2022)

Urinary retention (May 2023)

Urinary retention - 2Qs (November 2018)

Urinary retention - 2Qs (January 2022)

Urinary tract infection in pregnancy - 2Qs (March 2019)

Urinary tract stones - 4Qs (March 2025)

Uterine fibroids - 2Qs (January 2019)

UTI in nonpregnant women - 2Qs (March 2020)